School of Medical & Allied Sciences Faculty

Dr. Mohit Sanduja

Assistant Professor

Qualification: B. Pharm., M. Pharm. (Pharmaceutical Chemistry), PhD

College/University: G.R.D. Institute of Mgt. & Technology, Dehradun, I.S.F. College of Pharmacy, Moga, M.V.N. (Haryana State Private University), Palwal

Introduction: Mohit Sanduja is an expert in the area of synthetic medicinal chemistry. He has completed B. Pharm. from G.R.D. Institute of Mgt. & Technology, Dehradun (U.K.) in 2009, M. Pharm. (Pharmaceutical Chemistry) from I.S.F. College of Pharmacy, Moga (Punjab) and PhD from M.V.N. (Haryana State Private University), Palwal, Haryana.

He has started his carrier in 2011 as a Research associate (R&D) in the department of API chemical development at Ind-Swift Laboratories, Mohali (Punjab). He has more than 9 years of experience in teaching. He has published various national and international research papers in reputed pharmaceutical journals. He has authored 02 books with Indian publisher. He is also a member of numerous professional bodies like IPGA, IPES, PRISAL etc.

Publications (from 2016)

Scholarly Journals:

‘Aromatherapy as an adjunctive therapeutic paradigm in cancer treatment’. Anti-Cancer Agents Med. Chem (Sanduja, M. et al., 2021), (Article in press).

‘Illustrated Pharmacognostic Standardization of Ocimum kilimandscharicum’ Res J Pharm Technol., 13(11). (Sanduja, M. et al., 2020), pp. 5139-5144.

‘Meticulous Approach towards Pharmacognosy and Socio-economic Impact of Ethnomedicinal Plant: Ocimum kilimandscharicum’. Res J Pharm Technol. 13(10). (Sanduja, M. et al., 2020), pp. 4751-4764.

‘Designing, Molecular Docking and Dynamics Simulations Studies of 1, 2, 3-Triazole clamped Uracil-Coumarin Hybrids against EGFR tyrosine kinase’. J. Appl. Pharm. 10(03). (Sanduja, M. et al., 2020), pp. 001-011.

‘Uracil-coumarin based hybrid molecules as potent anti-cancer and anti-bacterial agents’. J. Saudi chem. Soc. 24. (Sanduja, M. et al., 2020), pp. 251-266.

‘Recent advancements in Uracil and 5-Fluorouracil hybrids as potential anticancer agents: A Review’. J. Appl. Pharm. 10(02). (Sanduja, M. et al., 2020), pp. 129-146.

‘Rational approaches, design strategies, structure activity relationship and mechanistic insights for therapeutic coumarin hybrids.’ Bioorg. Med. Chem. 27(16). (Sanduja, M. et al., 2019), pp. 3477-3510.

‘Rational approaches, design strategies, structure activity relationship and Mechanistic Insights for Esterase Inhibitors’. Mini Rev Med Chem. 18. (Sanduja, M. et al., 2018), pp. 837-894.

Books:

‘Text Book of Pharmaceutical Inorganic Chemistry’. (as per new curriculum of B.Pharmacy) Nirali Prakashan, Pune. (Sanduja, M. et al., 2018). ISBN No.: 978-93-86700-38-4.

‘Practical Book of Pharmaceutical Inorganic Chemistry’. (as per new curriculum of B.Pharmacy) Nirali Prakashan, Pune. (Sanduja, M. et al., 2018). ISBN No.: 978-93-86700-64-3.

Research:

Mohit Sanduja’s current research interests are focused on development of novel multiple targeted conjugates and hybrids molecules to fight with cancer with least toxicity to healthy cells.

Consultancies (from 2018) Nil

Contribution to the Profession and Awards (from 2012)

He has facilitated with ‘Dynamic Pharma Teacher Award’ in the IPES award ceremony 2020 organized by IPES, Lucknow in collaboration with Pharmatutor and St.Dominic College of Asia, Philippines on 08th Nov. 2020.

He has appointed as a ‘Vice Present of IPES (Haryana)’ by officiating apex members of Indian Pharma Education Society, Lucknow (Uttar Pradesh).

He won the ‘First Prize in Scientific Oral Paper Presentation’ at International e-Conference organized by Indian Pharmaceutical Association (IPA), U.P. State Branch jointly with I.T.S College of Pharmacy, India and Rejoice Health Foundation on 27 June, 2020.

He won the ‘Best Scientific Poster Award’ at International Conference, PharmaRIA (IPA Convention-2019) in Sept. 2019, held at Vigyan Bhawan, New Delhi, India.

He secured ‘3rd Position (at state level)’in Punjab Technical University during his post-graduation.